Evidence map›Paper›PMID 41267899›Full record

ReviewNAR genomics and bioinformatics2025

Benchmarking unsupervised methods for inferring TCR specificity.

Charline Jouannet, Hélène Vantomme, Kenz Le Gouge, David Klatzmann, Encarnita Mariotti-Ferrandiz

Abstract readReview
In one paragraph

Review in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Charline JouannetSorbonne Université, INSERM, Immunoregulation-Immunopathology-Immunotherapy (i3), 75005, Paris, France.
Hélène VantommeSorbonne Université, INSERM, Immunoregulation-Immunopathology-Immunotherapy (i3), 75005, Paris, France.ORCID https://orcid.org/0009-0008-8759-1208
Kenz Le GougeSorbonne Université, INSERM, Immunoregulation-Immunopathology-Immunotherapy (i3), 75005, Paris, France.
David KlatzmannSorbonne Université, INSERM, Immunoregulation-Immunopathology-Immunotherapy (i3), 75005, Paris, France.
Encarnita Mariotti-FerrandizSorbonne Université, INSERM, Immunoregulation-Immunopathology-Immunotherapy (i3), 75005, Paris, France.ORCID https://orcid.org/0000-0002-8770-0186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying T-cell receptor (TCR) specificity is crucial for advancing the understanding of adaptive immunity. Despite the development of computational methods to infer TCR specificity, their clustering behavior has not been thoroughly compared. We addressed this by curating a unified database of 190 670 human TCRs with known specificities for 2313 epitopes across 121 organisms, combining data from IEDB, McPAS-TCR, and VDJdb. We asked whether widely used TCR clustering methods produce comparable results on the same high-confidence dataset. We hypothesized that shared assumptions about conserved CDR3 motifs would yield similar patterns, with differences reflecting algorithmic design. Nine methods for clustering TCRs based on similarity were benchmarked against this dataset. DeepTCR demonstrated the best retention, while ClusTCR, TCRMatch, and GLIPH2 excelled in cluster purity but had lower retention. GLIPH2, Levenshtein distance, Hamming distance, and clusTCR generated large clusters in contrast to TCRMatch and DeepTCR. Smaller, antigen-specific clusters were produced by GIANA and iSMART. DeepTCR was the most sensitive in capturing antigen-specific TCRs. We confirmed these observations using a larger dataset from 10X Genomics containing antigen-specific labeled TCRs as well non-labeled cells. This study offers a unified TCR database and a benchmark of specificity inference methods, guiding researchers in selecting appropriate tools.

Indexed as

Computational BiologyReceptors, Antigen, T-CellAlgorithmsBenchmarkingCluster AnalysisHumansReceptors, Antigen, T-Cell

Identifiers

PMID41267899
PMCPMC12629845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.